Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,029	4,506	3,499	2,040	1,742	1,182
Market Cap Growth	28.76%	28.76%	71.56%	17.08%	47.34%	23.36%
Enterprise Value	4,342	3,819	2,909	1,642	1,388	899
Last Close Price	180.30	156.66	124.06	79.22	69.95	60.00
PE Ratio	58.19	50.54	320.10	-	-	-
Forward PE	24.58	33.31	-	-	-	-
PS Ratio	17.74	15.51	69.02	-	-	-
PB Ratio	5.49	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	4.76	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	42.66	37.81	-	-	-	-
P/OCF Ratio	41.20	36.51	-	-	-	-
EV/Sales Ratio	14.95	13.15	57.38	-	-	-
EV/EBITDA Ratio	41.10	36.14	-	-	-	-
EV/EBIT Ratio	42.08	37.01	-	-	-	-
EV/FCF Ratio	36.44	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.07	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.31	0.31	0.07	-	-	-
Inventory Turnover	1.20	1.20	-	-	-	-
Quick Ratio	6.89	6.89	17.35	13.14	17.02	17.56
Current Ratio	7.28	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	10.34%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	6.88%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	7.41%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	10.80%	10.80%	-	-	-	-
Earnings Yield	1.75%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.34%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-7.16%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q